Jane Street’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-384,770
Closed -$4.86M 12652
2025
Q4
$6.38M Buy
384,770
+277,508
+259% +$3.96M ﹤0.01% 2886
2025
Q3
$1.26M Buy
+107,262
New +$1.11M ﹤0.01% 5826
2025
Q1
Sell
-77,869
Closed -$473K 10332
2024
Q4
$632K Buy
77,869
+50,027
+180% +$620K ﹤0.01% 6280
2024
Q3
$503K Sell
27,842
-28,006
-50% -$391K ﹤0.01% 7168
2024
Q2
$575K Buy
55,848
+30,827
+123% +$318K ﹤0.01% 6785
2024
Q1
$266K Sell
25,021
-40,233
-62% -$342K ﹤0.01% 7741
2023
Q4
$596K Sell
65,254
-5,530
-8% -$47.6K ﹤0.01% 6465
2023
Q3
$734K Buy
70,784
+59,584
+532% +$817K ﹤0.01% 5635
2023
Q2
$160K Sell
11,200
-2,145
-16% -$24.7K ﹤0.01% 7777
2023
Q1
$95.3K Sell
13,345
-7,338
-35% -$64.5K ﹤0.01% 8251
2022
Q4
$232K Sell
20,683
-10,886
-34% -$112K ﹤0.01% 7438
2022
Q3
$350K Buy
+31,569
New +$301K ﹤0.01% 7334
2021
Q2
Sell
-8,193
Closed -$308K 10247
2021
Q1
$308K Buy
+8,193
New +$343K ﹤0.01% 7668

Other funds holding PHAT